Federated Hermes’s LENZ Therapeutics LENZ Stock Holding History

Federated Hermes’s Portfolio LENZ Stock Details LENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27.8K	Buy	+4,897	New	+$39.5K	﹤0.01%	1756
2026 Q1	–	Sell	-62,636	Closed	-$1M	–	2181
2025 Q4	$1M	Buy	+62,636	New	+$1.83M	﹤0.01%	1123
2025 Q1	–	Sell	-45	Closed	-$1.3K	–	2213
2024 Q4	$1.3K	Buy	+45	New	+$1.37K	﹤0.01%	2005
2023 Q3	–	Sell	-58,308	Closed	-$1.06M	–	2215
2023 Q2	$1.06M	Sell	58,308 -258	-0.4%	-$5.16K	﹤0.01%	1122
2023 Q1	$1M	Sell	58,566 -92,648	-61%	-$1.5M	﹤0.01%	1166
2022 Q4	$3.51M	Buy	151,214 +74	+0%	+$1.72K	0.01%	758
2022 Q3	$3.35M	Buy	151,140 +239	+0.2%	+$5.7K	0.01%	763
2022 Q2	$2.9M	Hold	150,901	–	–	0.01%	830
2022 Q1	$5.39M	Hold	150,901	–	–	0.01%	763
2021 Q4	$13.1M	Hold	150,901	–	–	0.02%	583
2021 Q3	$17.3M	Buy	150,901 +58,044	+63%	+$8.6M	0.03%	511
2021 Q2	$20M	Buy	+92,857	New	+$16.2M	0.04%	482

Other funds holding LENZ

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

AWG

Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

7IH

72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Federated Hermes's LENZ Position: Q2 2026 in Review

Federated Hermes opened a new position in LENZ Therapeutics (LENZ) in Q2 2026: 4,897 shares worth $27.8K. The stake represents ﹤0.01% of the portfolio and ranks #1756 among its holdings. This is a return to the name: Federated Hermes previously reported a position in LENZ as recently as Q4 2025.

Federated Hermes first reported a position in LENZ in Q2 2021 and has held it in 12 quarters since. The position peaked at $20M in Q2 2021. 144 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

Federated Hermes held 4,897 shares of LENZ Therapeutics worth $27.8K as of Q2 2026.
LENZ Therapeutics was a new Federated Hermes position in Q2 2026.
LENZ Therapeutics made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1756 holding.
Federated Hermes first reported a position in LENZ Therapeutics in Q2 2021 and has held it in 12 quarters since.
Federated Hermes's LENZ Therapeutics position peaked at $20M in Q2 2021.
144 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.